Related Experiment Video
Updated: Jul 16, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas
Yunes Panahi1, Mostafa Ghanei, Jafar Aslani
1Research Center for Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran. yunespanahi@yahoo.com.
Abstract:
Bronchiolitis has been known as one of the pathological features of lung injuries in mustard gas exposed patients.The purpose of this research was to evaluate the efficacy of interferon gamma-1b on the lung function in mustard gas exposed patients with bronchiolitis. In multicenter research interferon gamma-1b was effective in pulmonary fibrosis with unknown reason, but assessment of effect of interferon gamma-1b in the chemical injured patients has not so far been reported.Thirty six patients with bronchiolitis whose lung lesion had been diagnosed through the chest high resolution computerized tomography (HRCT) and pathological study were divided into two eighteen member case and control groups. The case group was treated for 6 months with a combination of 200 mug of interferon gamma-1b (given three times per week subcutaneously) and 7.5mg of prednisolone (given once a day), while the control group received their previous medications (prednisolone 7.5mg/day + salbutamol and beclomethasone spray PRN).In the two groups, FEV1 did not have statistical differences at base line (49.3+/-2.9 and 48.7+/-4.1, respectively, p = 0.6), whereas after treatment the data for FEV1 showed a significant increase in the case group (66.3+/-5.4) when compared with those in the control group (57.3+/-8.6, p=0.001). The findings of this study indicate that a 6-month treatment with interferon gamma -1b plus a low-dose of prednisolone is associated with the improvement of the lung function in mustard gas exposed patients with bronchiolitis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation